Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CHA Taking Stem Cell-Based Alzheimer’s Therapy Into Clinic

This article was originally published in PharmAsia News

Executive Summary

South Korea's CHA Biotech is set to begin the first clinical trial of a mesenchymal stem cell therapy for Alzheimer's disease, which the company plans to develop on a commercial scale by using proprietary technology that can store the cells for up to 24 months.



Related Companies